Blog Posts

THEY SAID IT! HOUSE LAWMAKERS MAINTAIN COMMITMENT TO BIPARTISAN COOPERATION ON DRUG PRICING

Sep 26, 2019

House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma Read More

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA FOR “GAMING THE SYSTEM” TO BLOCK COMPETITION

Sep 20, 2019

Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action Read More

Big Pharma Watch: Drug Maker Hit With $15 Million Penalty for Illegal Price Hike Scheme

Sep 10, 2019

In case you missed it, a recent article in HealthLeaders details how brand Read More

What They Are Saying: Americans Urge Action to Lower Drug Prices, Hold Big Pharma Accountable

Aug 29, 2019

Voices From Around the Country Call for Congress to Pass Senate Finance Read More

Big Pharma Watch: How Drug Makers Use Charities to Pad Their Bottom Line

Aug 29, 2019

In case you missed it, a recent article in The Economist digs into the inner Read More

Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability

Aug 22, 2019

BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more Read More

Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game

Aug 16, 2019

Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Read More

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability

Jul 31, 2019

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Read More

Big Pharma Earnings Watch: Amgen, Eli Lilly, Merck and Pfizer

Jul 31, 2019

Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After Read More

Big Pharma Earnings Watch: AbbVie and Sanofi

Jul 30, 2019

Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices Read More

Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche

Jul 29, 2019

Three More Drug Makers Top Earnings Expectations in Q2   Today three more Read More

Big Pharma Earnings Watch: GlaxoSmithKline

Jul 24, 2019

Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices Read More